Are Meghmani Organics Ltd latest results good or bad?

1 hour ago
share
Share Via
Meghmani Organics Ltd's latest Q4 FY26 results are concerning, showing a 14.30% decline in net sales and a 59.49% drop in net profit year-on-year, alongside weakened operating margins and financial sustainability issues. The company's performance indicates significant operational challenges and a need for strategic restructuring.
Meghmani Organics Ltd's latest financial results for Q4 FY26 indicate significant operational challenges. The company reported net sales of ₹474.34 crores, reflecting a year-on-year contraction of 14.30%, which marks the lowest quarterly revenue in the past seven quarters. This decline in sales is accompanied by a notable decrease in operating margins, which fell to 4.16%, the weakest level observed in recent quarters. The operating profit before depreciation, interest, tax, and other income (PBDIT excluding other income) dropped sharply to ₹19.72 crores, indicating severe pressure on the company's pricing power and cost structures.
Net profit for the quarter was ₹8.03 crores, which represents a substantial decline of 59.49% year-on-year. The profit before tax was heavily reliant on other income, which constituted over 520% of the profit before tax, raising concerns about the sustainability of the company's core operations. The operating profit-to-interest coverage ratio fell to 0.96 times, suggesting that the company is barely generating enough operating profit to cover its interest obligations, a situation that poses risks to financial sustainability. The company also experienced a decline in return on equity (ROE), averaging just 6.03%, which is below industry standards for capital-intensive chemical businesses. Furthermore, the shareholding pattern indicates a trend of institutional disinterest, with a notable lack of mutual fund and insurance company holdings, while non-institutional holdings have increased, suggesting a divergence in investor sentiment. Overall, Meghmani Organics Ltd's financial performance reflects a company facing significant operational and financial challenges, with multiple indicators pointing towards a need for strategic restructuring to address the underlying issues. The company saw an adjustment in its evaluation, reflecting these deteriorating fundamentals.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News